Alpha DNA Investment Management’s 1st Source SRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,787
Closed -$466K 251
2024
Q3
$466K Buy
+7,787
New +$459K 0.17% 132
2024
Q2
Sell
-11,742
Closed -$616K 241
2024
Q1
$616K Buy
+11,742
New +$602K 0.23% 98

Other funds holding SRCE

Alpha DNA Investment Management's SRCE Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of 1st Source (SRCE) in Q4 2024, closing a stake of 7,787 shares — an estimated $466K sold.

Alpha DNA Investment Management first reported a position in SRCE in Q1 2024 and held it in 2 quarters. The position peaked at $616K in Q1 2024. 188 funds tracked by Wall St. Rank hold SRCE as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining 1st Source position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,787 1st Source shares in Q4 2024, an estimated $466K.
  • Alpha DNA Investment Management first reported a position in 1st Source in Q1 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's 1st Source position peaked at $616K in Q1 2024.
  • 188 funds tracked by Wall St. Rank held 1st Source as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.